Evidence map›Paper›PMID 35661853›Full record

ArticleNanoscale2022

Wei Luo, Hironaga Noguchi, Chen Chen, Yoshiki Nakamura, Chishu Homma, Oleksii Zozulia, Ivan V Korendovych, Yuhei Hayamizu

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Catalytic Amyloids: Turning Fibrils Into Biocatalysts.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Wei LuoDepartment of Materials Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology, Tokyo 152-8550, Japan. hayamizu.y.aa@m.titech.ac.jp.
Hironaga NoguchiDepartment of Materials Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology, Tokyo 152-8550, Japan. hayamizu.y.aa@m.titech.ac.jp.
Chen ChenDepartment of Materials Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology, Tokyo 152-8550, Japan. hayamizu.y.aa@m.titech.ac.jp.ORCID http://orcid.org/0000-0002-4880-3617
Yoshiki NakamuraDepartment of Materials Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology, Tokyo 152-8550, Japan. hayamizu.y.aa@m.titech.ac.jp.
Chishu HommaDepartment of Materials Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology, Tokyo 152-8550, Japan. hayamizu.y.aa@m.titech.ac.jp.
Oleksii ZozuliaDepartment of Chemistry, Syracuse University, Syracuse, New York 13244, USA.ORCID http://orcid.org/0000-0003-3803-4225
Ivan V KorendovychDepartment of Chemistry, Syracuse University, Syracuse, New York 13244, USA.ORCID http://orcid.org/0000-0001-8144-783X
Yuhei HayamizuDepartment of Materials Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology, Tokyo 152-8550, Japan. hayamizu.y.aa@m.titech.ac.jp.ORCID http://orcid.org/0000-0003-1411-9400
Tokyo Institute of Technology · JPSyracuse University · US

Funding

Understanding Evolution of Protein Function Through Design.R35GM119634 · NIGMS · SYRACUSE UNIVERSITY · PI KORENDOVYCH, IVAN V · 2016 to 2025
$4.3M
NIGMS NIH HHS R35 GM119634
6 · The paper itself

Abstract

Here we demonstrate that short peptides,

Indexed as

GraphiteCatalysisHeminPeptidesGraphiteHeminPeptides

Identifiers

PMID35661853
PMCPMC9202597
OpenAlexW4282921906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.